← Open Payments lookup

JULIANA SMITH: Open Payments

NPI 1912544875 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$786 in 40 payments from 13 companies in 2025. Trend: 2023 $379 · 2024 $631 · 2025 $786

Food & beverage: $786
CompanyPaymentsAmount
Novo Nordisk Inc17$242
AstraZeneca Pharmaceuticals LP5$155
PFIZER INC.3$73
Averitas Pharma Inc.2$55
Boston Scientific Corporation1$43
Astellas Pharma US Inc3$42
Lilly USA, LLC2$37
GlaxoSmithKline, LLC.2$29
BridgeBio Pharma, Inc.1$28
Boehringer Ingelheim Pharmaceuticals, Inc.1$22

Products named: Ozempic, FARXIGA, Wegovy, PREVNAR 20, QUTENZA, APOLLO ESG System, Veozah, Attruby.

Industry payments across TX — which companies pay providers there.